9:22 AM
Leo Group India
| ||
| Pharmaceutical companies cheer as Mormugao Port Trust gets notified port status Times of India PANAJI: The pharmaceutical industry in the state has reason to rejoice. The much awaited final notification giving the status of a notified port to Mormugao port has been issued. With this, the doors are now opened for import of pharmaceuticals through Goa's ... See all stories on this topic » | ||
| Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors Sacramento Bee SOLANA BEACH, Calif., July 27, 2012 -- /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (OTC Markets Group: IMMY), a specialty pharmaceutical company developing non-invasive topically delivered products, announced that Stephen G. Austin, CPA has ... See all stories on this topic » | ||
| Pharmaceutical Manufacturers Attempt to Safeguard Business Continuity from ... Sacramento Bee CHAPEL HILL, N.C., July 27, 2012 -- /PRNewswire/ -- Bio-Pharmaceutical and medical device leaders are re-evaluating their crisis management preparation and processes in light of recent major disasters that have disrupted supply chains and global ... See all stories on this topic » | ||
| Acura Pharmaceuticals Announces Update on AVERSION Products MarketWatch (press release) About Acura Pharmaceuticals Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address medication abuse and misuse, utilizing its proprietary ... See all stories on this topic » | ||
| NPS Pharmaceuticals to Report Second Quarter 2012 Financial Results MarketWatch (press release) BEDMINSTER, N.J., Jul 27, 2012 (BUSINESS WIRE) -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) announced today that it will report its second quarter 2012 financial results on Wednesday, August 1, 2012 at approximately 4:30 p.m. ET. The press release ... See all stories on this topic » | ||
| PROGENICS PHARMACEUTICALS, INC. : Salix and Progenics Receive ... 4-traders Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today received at approximately 5:00 p.m. ET a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following its review of a ... See all stories on this topic » | ||
| Mylan launches generic Sporanox capsules in US pharmabiz.com This product is the generic version of Janssen Pharmaceutical Inc.'s Sporanox and is indicated for the treatment of fungal infections that begin in the lungs, blatsomycosis, histoplasmosis, and aspergillosis in patients who are intolerant of or who are refractory ... See all stories on this topic » | ||
| Pfizer to return rights to three Acura products Economic Times The pharmaceutical giant will retain rights to Oxecta -- a pain management pill that also uses Acura's technology -- which is already on the market, Acura said. Pfizer will return all assets and regulatory and clinical responsibility related to the three drugs, ... See all stories on this topic » | ||
| ACI Maximizing Pharmaceutical Patent Lifecycles Conference Patent Docs American Conference Institute (ACI) will be holding its 13th Annual Maximizing Pharmaceutical Patent Lifecycles conference on October 10-11, 2012 in New York, NY. The conference will allow attendees to: • Understand how the patent cliff will impact ... See all stories on this topic » | ||
| Calls for a rethink on Hormone Replacement Therapy ABC Online ELIZABETH JACKSON: The country's health regulator and the pharmaceutical industry are both being asked to help millions of Australian women, whom doctors say are suffering unnecessarily. It's been 10 years since an alarming US study found that ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment